Compare MTN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTN | TMDX |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.6B |
| IPO Year | 1997 | 2019 |
| Metric | MTN | TMDX |
|---|---|---|
| Price | $136.75 | $129.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $173.17 | $144.25 |
| AVG Volume (30 Days) | ★ 826.2K | 753.2K |
| Earning Date | 03-09-2026 | 02-24-2026 |
| Dividend Yield | ★ 6.34% | N/A |
| EPS Growth | 17.26 | ★ 170.70 |
| EPS | ★ 7.24 | 2.54 |
| Revenue | ★ $2,975,101,000.00 | $566,354,000.00 |
| Revenue This Year | $1.78 | $38.73 |
| Revenue Next Year | $3.98 | $20.55 |
| P/E Ratio | ★ $19.33 | $52.56 |
| Revenue Growth | 3.06 | ★ 41.20 |
| 52 Week Low | $126.16 | $62.07 |
| 52 Week High | $175.51 | $156.00 |
| Indicator | MTN | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 43.77 |
| Support Level | $135.99 | $127.00 |
| Resistance Level | $145.89 | $140.72 |
| Average True Range (ATR) | 4.95 | 6.68 |
| MACD | 0.88 | -0.70 |
| Stochastic Oscillator | 56.52 | 13.23 |
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.